Oxycodone FC Tablet is a premium Finished Dosage Form (FDF) and a potent pure opioid agonist manufactured by Parand Darou Co. Engineered for clinical efficacy, Oxycodone acts primarily on central μ-opioid receptors to deliver robust analgesic relief. It is indicated for the management and relief of moderate-to-severe pain, particularly severe post-operative recovery, trauma-induced pain, and persistent oncological (cancer) pain conditions that remain refractory to non-opioid therapeutic alternatives.
Therapeutic Strengths, Appearance & Packaging
Oxycodone film-coated tablets are produced in three distinct therapeutic strengths: 5 mg, 15 mg, and 30 mg, formulated as Round-Biconvex solid oral dosages. To ensure maximum physicochemical integrity and barrier protection against humidity and light degradation, the tablets are supplied in medical-grade blister packs (ALU-PVC), with each carton containing 3 blisters of 10 tablets (30 tablets per box).
Regulatory Status & Dispensing Protocols
This product is strictly categorized as an under control medicine. Prescribing and dispensing are restricted exclusively to validated specialist prescriptions under rigorous pharmacovigilance and statutory protocols regulated by the Food and Drug Administration.
General Information
| Generic Name | Oxycodone Tablet | |
| Brand Name | – | |
| Manufacturer | Parand Darou Co. |
Specification
| Dosage Form | FC Tablet | |
| Strength | 5 mg, 15 mg, 30 mg | |
| Appearance | Round-Biconvex | |
| Packaging | Each box contains 3 blisters (ALU-PVC) of 10’s | |
| OTC/Prescription/Supplement | Prescription | |
| Route of Administration | ORAL | |
| Access Level | Under control medicine | |
| Category | Opioid Analgesic / Severe pain management |
